Catheter-directed thrombolysis and mechanical intervention in deep venous thrombosis: what is the status after the ATTRACT trial?

References

• Heit J, Silverstein M, Mohr D, et al. The epidemiology of venous thromboembolism in the community. J Thromb Haemost. 2001;86:452–463.
   Google Scholar
• Beckman MG, Hooper WC, Critchley SE, et al. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4):S495–S501.
   PubMed Web of Science ®Google Scholar
• Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Haemost. 2016;41:3–14.
   Google Scholar
• Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–593.
   PubMed Web of Science ®Google Scholar
• Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117(1):19–25.
   PubMed Web of Science ®Google Scholar
• Spencer FA, Emery C, Lessard D, et al. The worcester venous thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006;21(7):722–727.
   PubMed Web of Science ®Google Scholar
• Ia NÆSS, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692–699.
   PubMed Web of Science ®Google Scholar
• Spencer FA, Emery C, Joffe SW, et al. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolismThe worcester VTE study. J Thromb Haemost. 2009;28:401.
   Google Scholar
• Tagalakis V, Patenaude V, Kahn SR, et al. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort. Am J Med. 2013;126(9):832.e13–832.e21.
   PubMed Web of Science ®Google Scholar
• Huang W, Goldberg RJ, Anderson FA, et al. Secular trends in occurrence of acute venous thromboembolism: the worcester VTE study (1985-2009). Am J Med. 2014;127(9):829–839.e5.
   Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. CHEST. 2016;149:315–352.
   PubMed Web of Science ®Google Scholar
• Prandoni P, Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125(1):1–7.
   PubMed Web of Science ®Google Scholar
• Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Ann Intern Med. 2000;160(6):761–768.
   Google Scholar
• Hansson P-O, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Ann Intern Med. 2000;160(6):769–774.
   Google Scholar
• Schulman S, Lindmarker P, Holmström M, et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost. 2006; 4:734–742.
   PubMed Web of Science ®Google Scholar
• Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. haematol. 2007;92:199–205.
   PubMed Web of Science ®Google Scholar
• Cjj VD, Vink R, Hutten BA, et al. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis. Arch Intern Med. 2003;163(11):1285–1293.
   PubMedGoogle Scholar
• Spencer FA, et al. Patient outcomes after deep vein thrombosis and pulmonary embolism the worcester venous thromboembolism study. Arch Intern Med. 2008;168(4):425–430.
   PubMedGoogle Scholar
• Nieto JA, Camara T, Gonzalez-Higueras E, et al. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE registry. J Thromb Haemost. 2008;100:789–796.
   Google Scholar
• White RH, Chan W-S, Zhou H, et al. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. J Thromb Haemost. 2008;100:246–252.
   Google Scholar
• Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet. 2010;376(9757):2032–2039.
   PubMed Web of Science ®Google Scholar
• Verso M, Agnelli G, Ageno W, et al. Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry. Thromb Res. 2012;130(3):369–373.
   PubMed Web of Science ®Google Scholar
• Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis. 2009;28(4):465–476.
   PubMed Web of Science ®Google Scholar
• Farrell JJ, Sutter C, Tavri S, et al. Incidence and interventions for post-thrombotic syndrome. Cardiovasc Diagn Ther. 2016;6(6):623–631.
   PubMed Web of Science ®Google Scholar
• Fleck D, Albadawi H, Shamoun F, et al. Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations. Cardiovasc Diagn Ther. 2017;7(S3):S228–S237.
   PubMedGoogle Scholar
• Kahn SR, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008;149(10):698–707.
   PubMed Web of Science ®Google Scholar
• Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program. 2016;2016(1):413–418.
   PubMedGoogle Scholar
• Goktay AY, Senturk C. Endovascular Treatment of Thrombosis and Embolism. In: Islam M, editor. Thrombosis and embolism: from research to clinical practice: volume 1. Cham: Springer International Publishing; 2017. p. 195–213. 10.1007/5584_2016_116.
   Google Scholar
• Stain M, Schönauer V, Minar E, et al. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost. 2005;3(12):2671–2676. .
   PubMed Web of Science ®Google Scholar
• Guanella R, Ducruet T, Johri M, et al. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost. 2011;9(12):2397–2405.
   PubMed Web of Science ®Google Scholar
• MacDougall DA, Feliu AL, Boccuzzi SJ, et al. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health Syst Pharm. 2006;63(20_Supplement_6):S5–S15.
   PubMedGoogle Scholar
• Bergan JJ, Schmid-Schönbein GW, Smith PDC, et al. Chronic venous disease. N Engl J Med. 2006;355(5):488–498.
   PubMed Web of Science ®Google Scholar
• Prandoni P, Prandoni P, Lensing AWA, Prins MH, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Inter Med. 2002;137(12):955–960.
   PubMed Web of Science ®Google Scholar
• Prandoni P, Frulla M, Sartor D, et al. Vein abnormalities and the post-thrombotic syndrome. J Thromb Haemost. 2005;3(2):401–402.
   PubMed Web of Science ®Google Scholar
• Enden T, Haig Y, N-e K, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379(9810):31–38.
   PubMed Web of Science ®Google Scholar
• Sudheendra D, Catheter-Directed Therapy VS. Options for Iliofemoral Venous Thrombosis. Surg Clin North Am. 2018;98(2):255–265.
   PubMed Web of Science ®Google Scholar
• Mewissen MW, Seabrook GR, Meer MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39–49.
   PubMed Web of Science ®Google Scholar
• Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis A randomised clinical trial. Eur J Vasc Endovasc Surg. 2002;24(3):209–214. The Official Journal of the European Society for Vascular Surgery.
   PubMed Web of Science ®Google Scholar
• Baekgaard N, Broholm R, Just S, et al. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg. 2010;39(1):112–117.
   PubMed Web of Science ®Google Scholar
• Comerota AJ, Grewal N, Martinez JT, et al. Postthrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosis. J Vasc Surg. 2012;55(3):768–773.
   PubMed Web of Science ®Google Scholar
• Watson L, Broderick C, Armon MP Thrombolysis for acute deep vein thrombosis. Cochrane database of systematic reviews. 2016; Available from: https://www.readcube.com/articles/10.1002%2F14651858.CD002783.pub4
   Google Scholar
• Haig Y, Enden T, Grøtta O, et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol. 2016;3(2):e64–e71.
   PubMed Web of Science ®Google Scholar
• Aziz F, Comerota AJ. Quantity of residual thrombus after successful catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with recurrence. Eur J Vasc Endovascular Surg. 2012;44(2):210–213.
   PubMed Web of Science ®Google Scholar
• Vedantham S, Goldhaber SZ, Julian JA, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377(23):2240–2252.
   PubMed Web of Science ®Google Scholar
• Lin PH, Ochoa LN, Duffy P. Catheter-directed thrombectomy and thrombolysis for symptomatic lower-extremity deep vein thrombosis: review of current interventional treatment strategies. Perspect Vasc Surg Endovasc Ther. 2010;22(3):152–163.
   PubMedGoogle Scholar
• Kasirajan K, Gray B, Ouriel K. Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. JVIR. 2001;12(2):179–185.
   Google Scholar
• Pouncey AL, Gwozdz AM, Johnson OW, et al. AngioJet pharmacomechanical thrombectomy and catheter directed thrombolysis vs. catheter directed thrombolysis alone for the treatment of iliofemoral deep vein thrombosis: a single centre retrospective cohort study. Eur J Vasc Endovasc Surg. 2020;60:578–585.
   PubMed Web of Science ®Google Scholar
• Vedantham S, Vesely TM, Parti N, et al. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. JVIR. 2002;13(10):1001–1008.
   Google Scholar
• Lin PH, Zhou W, Dardik A, et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg. 2006;21(6):782–788.
   Google Scholar
• O’Sullivan GJ, Lohan DG, Gough N, et al. Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter. JVIR. 2007;18(6):715–724.
   Google Scholar
• Arko FR. Aggressive percutaneous mechanical thrombectomy of deep venous thrombosis: early clinical results. Arch Surg. 2007;127(6):513.
   Google Scholar
• Shi Y, Shi W, Chen L, et al. A systematic review of ultrasound-accelerated catheter-directed thrombolysis in the treatment of deep vein thrombosis. J Thromb Thrombolysis. 2018;45(3):440–451.
   PubMed Web of Science ®Google Scholar
• Kohi MP, Kohlbrenner R, Kolli KP, et al. Catheter directed interventions for acute deep vein thrombosis. Cardiovasc Diagn Ther. 2016;160(6):599–611.
   Google Scholar
• Kearon C, Gu C-S, Julian JA, et al. Pharmacomechanical catheter-directed thrombolysis in acute femoral-popliteal deep vein thrombosis: analysis from a stratified randomized trial. Thromb Haemost. 2019;119(4):633–644.
   PubMed Web of Science ®Google Scholar
• Comerota AJ, Kearon C, Gu C-S, et al. Endovascular thrombus removal for acute iliofemoral deep vein thrombosis: analysis from a stratified multicenter randomized trial. Circulation. 2019;139(9):1162–1173.
   PubMed Web of Science ®Google Scholar
• Razavi MK, Jaff MR, Miller LE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and meta-analysis. Circ Cardiovasc Interv. 2015; 8 Available from10: https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.115.002772
   PubMed Web of Science ®Google Scholar
• Yin M, Shi H, Ye K, et al. Clinical assessment of endovascular stenting compared with compression therapy alone in post-thrombotic patients with iliofemoral obstruction. Eur J Vasc Endovasc Surg. 2015;50(1):101–107.
   PubMed Web of Science ®Google Scholar
• Ruihua W, Xin W, Guang L, et al. Technique and clinical outcomes of combined stent placement for postthrombotic chronic total occlusions of the iliofemoral veins. J Vasc Interv Radiol. 2017;28(3):373–379.
   PubMed Web of Science ®Google Scholar
• Razavi M, Marston W, Black S, et al. The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2018;6:192–200.
   PubMedGoogle Scholar
• Williams ZF, Dillavou ED, Williams ZF, et al. A systematic review of venous stents for iliac and venacaval occlusive disease. J Vasc Surg Venous. 2020;8(1):145–153.
   PubMed Web of Science ®Google Scholar
• Xu J, Lo S. Fundamentals and role of intravascular ultrasound in percutaneous coronary intervention. Cardiovasc Diagn Ther. 2020;10(5):1358–1370.
   PubMed Web of Science ®Google Scholar
• McLafferty RB The role of intravascular ultrasound in venous thromboembolism. Seminars in Interventional Radiology. 2012;29:10–15.
   Google Scholar
• Neglén P, Raju S. Intravascular ultrasound scan evaluation of the obstructed vein. J Vasc Surg. 2002;35(4):694–700.
   PubMed Web of Science ®Google Scholar
• Raju S, Davis M, Martin A. Assessment of residual thrombus after venous thrombolytic regimens. J Vasc Surg Venous Lymphat Disord. 2014;2:148–154.
   PubMedGoogle Scholar
• Lopez R, DeMartino R, Fleming M, et al. Aspiration thrombectomy for acute iliofemoral or central deep venous thrombosis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2019;7(2):162–168.
   PubMedGoogle Scholar
• Loffroy R, Falvo N, Guillen K, et al. Single-session percutaneous mechanical thrombectomy using the aspirex®s device plus stenting for acute iliofemoral deep vein thrombosis: safety, efficacy, and mid-term outcomes. Diagnostics (Basel). 2020;10(8):544.
   Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease. Chest. 2016;149:315–352.
   PubMed Web of Science ®Google Scholar
• Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American heart association. Circulation. 2011;123(16):1788–1830.
   PubMed Web of Science ®Google Scholar
• Vedantham S, Sista AK, Klein SJ, et al. Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. JVIR. 2014;25(9):1317–1325.
   Google Scholar